Typical Uses:
Managing type 2 diabetes
Promoting weight loss in overweight or obese individuals
Reducing cardiovascular risk factors and events
Improving overall glycemic control
 
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes and obesity. It works by mimicking the action of GLP-1, a hormone that regulates blood sugar levels by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying. These actions help to control blood glucose levels and reduce appetite, leading to significant weight loss. Semaglutide has also been shown to provide cardiovascular benefits, reducing the risk of major cardiovascular events in patients with diabetes.
 
Benefits:
Blood Sugar Control: Helps regulate blood sugar levels.
Weight Loss: Promotes significant weight loss through appetite suppression.
Cardiovascular Benefits: May reduce the risk of cardiovascular events in patients with diabetes.
Improved Glycemic Control: Enhances overall glycemic control.
 
Possible Side Effects:
Gastrointestinal Issues: Nausea, vomiting, diarrhea, and constipation are possible.
Decreased Appetite: Can significantly reduce appetite.
Injection Site Reactions: Pain, redness, or swelling at the injection site.